Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SARTORIUS (SARTF : OTC)

• Company Description    Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. Number of Employees: 13,528

• Price / Volume Information    Yesterday's Closing Price: $225.00 Daily Weekly Monthly 20 Day Moving Average: 0 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 0.95 52 Week High: $243.35 52 Week Low: $165.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.27% 2.45% 12 Week 5.60% 3.90% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL OTTO-BRENNER-STRASSE 20 - GOETTINGEN,2M 37079 DEU ph: 49-55-130-80 fax: 49-55-1308-3289 ben.orzelek@sartorius.com http://www.sartorius.com

• General Corporate Information    Officers Joachim Kreuzburg - Chief Executive Officer and Chairman Florian Funck - Chief Financial Officer Rene Faber - Member of the Executive Board Alexandra Gatzemeyer - Member of the Executive Board Rainer Lehmann - Member of the Executive Board Peer Information SARTORIUS (ABMD) SARTORIUS (DMDS) SARTORIUS (CPWY.) SARTORIUS (EQUR) SARTORIUS (ECIA) SARTORIUS (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: D6705R101 SIC: 3843 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/16/26 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 0.95 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/16/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 44.73 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 31.25% vs. Previous Quarter: -8.70% Sales Growth vs. Year Ago Period: 13.01% vs. Previous Quarter: -1.77% ROE 12/31/25 - - 09/30/25 - 8.19 06/30/25 - 7.79 ROA 12/31/25 - - 09/30/25 - 3.15 06/30/25 - 2.98 Current Ratio 12/31/25 - - 09/30/25 - 0.95 06/30/25 - 1.39 Quick Ratio 12/31/25 - - 09/30/25 - 0.49 06/30/25 - 0.88 Operating Margin 12/31/25 - - 09/30/25 - 8.97 06/30/25 - 8.63 Net Margin 12/31/25 - - 09/30/25 - 3.82 06/30/25 - 3.00 Pre-Tax Margin 12/31/25 - - 09/30/25 - 8.16 06/30/25 - 6.67 Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - - Inventory Turnover 12/31/25 - - 09/30/25 - 2.34 06/30/25 - 2.31 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.89 06/30/25 - 1.08 Debt-to-Capital 12/31/25 - - 09/30/25 - 47.18 06/30/25 - 51.87

Powered by Zacks Investment Research ©